Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

COX-2 and Bcl-2 proteins are involved in Lichen Planus.

New compounds may soon be tested to treat excessive hair growth in women.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

TGM3 is important for skin and hair structure and may help diagnose cancer.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Skin cancer in sun-exposed areas is more likely to come back.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

THA is a rare condition with no significant clinical consequences if thyroid function is normal.

The document suggests a bacteria plays a significant role in acne rosacea and that white hair can regain color after transplant, meriting more research on reversing grey hair.